[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611953":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":62,"collaborators":7,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":7,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":7,"enrollmentInfo":73,"targetDuration":7,"studyType":76,"phases":7,"briefSummary":77,"conditions":78,"keywords":7,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[15,27,34,41,48,55],{"facility":16,"status":17,"city":18,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":7},"Research Site","RECRUITING","Kazan'","Russia","RU",{"type":22,"coordinates":23},"Point",[24,25],49.12214,55.78874,{"lat":25,"lon":24},{"facility":16,"status":17,"city":28,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":29,"geoPoint":33,"contacts":7},"Moscow",{"type":22,"coordinates":30},[31,32],37.61781,55.75204,{"lat":32,"lon":31},{"facility":16,"status":17,"city":35,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":36,"geoPoint":40,"contacts":7},"Novosibirsk",{"type":22,"coordinates":37},[38,39],82.93175,55.02259,{"lat":39,"lon":38},{"facility":16,"status":17,"city":42,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":43,"geoPoint":47,"contacts":7},"Rostov-on-Don",{"type":22,"coordinates":44},[45,46],39.70769,47.21997,{"lat":46,"lon":45},{"facility":16,"status":17,"city":49,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":50,"geoPoint":54,"contacts":7},"Saint Petersburg",{"type":22,"coordinates":51},[52,53],30.31413,59.93863,{"lat":53,"lon":52},{"facility":16,"status":17,"city":56,"state":7,"zip":7,"country":19,"countryCode":20,"cosmosGeoPoint":57,"geoPoint":61,"contacts":7},"Samara",{"type":22,"coordinates":58},[59,60],50.13553,53.20767,{"lat":60,"lon":59},{"type":63,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100611953","epidemiological-study-of-treatment-approaches-in-achr-antibody-positive-generalized-myasthenia-gravis-in-russia-100611953",false,"NCT07247279","Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia","A Multicenter Non Interventional Single Arm Retrospective-prospective Observational Study in Therapeutic Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis (gMG) in Real Clinical Practice in Russia","Inclusion Criteria:\n\n1. Adults (≥18 years) diagnosed with generalized MG positive for acetylcholine receptor (AChR) antibodies.\n2. Provision of signed and dated written informed consent.\n\nExclusion Criteria:\n\n1. Participants currently enrolled in clinical studies for treatment of gMG.\n2. Ocular MG only.","ALL","18 Years",{"count":74,"type":75},450,"ESTIMATED","OBSERVATIONAL","This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.",[79,80],"Rare Diseases","Generalized Myasthenia Gravis (gMG)","2026-06-12",{"date":83,"type":84},"2026-06-15","ACTUAL",{"date":86,"type":84},"2025-12-23",{"date":88,"type":75},"2029-12-31",{"name":5,"class":6},6]